Reverse transcriptase and corresponding activity-blocking antibody for monitoring SIVsm infection in macaques

被引:7
作者
Ekstrand, DHL
Bottiger, D
Andersson, H
Gronowitz, JS
Clas, FRK
机构
[1] CAVIDITECH AB,S-75183 UPPSALA,SWEDEN
[2] UNIV UPPSALA,BMC,DEPT MED GENET,S-75123 UPPSALA,SWEDEN
[3] SMI,MEDIVIR AB,S-10521 STOCKHOLM,SWEDEN
[4] UPPSALA UNIV,BMC,DEPT MOL BIOL,S-75124 UPPSALA,SWEDEN
关键词
D O I
10.1089/aid.1997.13.601
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A nonradioactive reverse transcriptase (RT) assay was used to measure RT activity in serum during the viremia peak associated with primary infection and for measuring the generation and maintenance of RT activity-blocking antibody (RTb-ab) titers during and after seroconversion in SIV-infected macaques, The RT assay was compared to an antigen capture immunoassay designed for HIV-2/SIVsm and was found to be approximately 40 times more sensitive in detecting SIVsm in serum from infected macaques, The RT assay detected RT activity in serum corresponding to levels from 3 pg/ml. Earliest detection of viral replication using the RT assay was on day 6-8, with a peak at day 10 (up to 8000 pg/ml), The earliest detection of RTb-ab was seen on day 17-23, with established RTb-ab titers by day 29, followed by increasing titers of 15,000-120,000 by day 62-77, The usefulness of RT and RTb-ab for monitoring the course of SIV infection in monkey models is discussed.
引用
收藏
页码:601 / 610
页数:10
相关论文
共 41 条
[1]   CROSS-SECTIONAL STUDY OF REVERSE TRANSCRIPTASE-INHIBITING ANTIBODY AS A MARKER OF ACQUIRED IMMUNE-DEFICIENCY SYNDROME [J].
ADVANI, M ;
IMAGAWA, DT ;
LEE, MH ;
SANO, K ;
MORALES, F ;
MITSUYASU, RT ;
DETELS, R .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (07) :1453-1455
[2]   ISOLATION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) FROM PLASMA DURING PRIMARY HIV-INFECTION [J].
ALBERT, J ;
GAINES, H ;
SONNERBORG, A ;
NYSTROM, G ;
PEHRSON, PO ;
CHIODI, F ;
VONSYDOW, M ;
MOBERG, L ;
LIDMAN, K ;
CHRISTENSSON, B ;
ASJO, B ;
FENYO, EM .
JOURNAL OF MEDICAL VIROLOGY, 1987, 23 (01) :67-73
[3]  
ALBERT J, 1992, DIAGNOSIS HUMAN VIRU, P3
[4]  
ALLAN JS, 1987, BLOOD, V69, P331
[5]  
ANDERSSON HO, 1997, UNPUB VIROLOGY
[6]  
AWAD RJK, 1977, IN PRESS J CLIN MICR, V35
[7]   VIRUS-LIKE PARTICLES ASSOCIATED WITH REVERSE-TRANSCRIPTASE ACTIVITY IN ACUTE SPORADIC NON-A, NON-B HEPATITIS [J].
CASTILLO, I ;
CARRENO, V ;
BARTOLOME, FJ ;
PORRES, JC ;
MORA, I ;
HERRERA, MI .
DIGESTION, 1989, 42 (01) :7-15
[8]   IMMUNOGENICITY OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) REVERSE-TRANSCRIPTASE - DETECTION OF HIGH-LEVELS OF ANTIBODIES TO HIV REVERSE-TRANSCRIPTASE IN SERA OF HOMOSEXUAL MEN [J].
CHATTERJEE, R ;
RINALDO, CR ;
GUPTA, P .
JOURNAL OF CLINICAL IMMUNOLOGY, 1987, 7 (03) :218-224
[9]   HIGH PREVALENCE OF SERUM ANTIBODIES TO REVERSE-TRANSCRIPTASE IN HIV-1-INFECTED INDIVIDUALS [J].
DEVICO, AL ;
VERONESE, FD ;
LEE, SL ;
GALLO, RC ;
SARNGADHARAN, MG .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1988, 4 (01) :17-22
[10]   A NEW METHOD FOR MEASURING REVERSE-TRANSCRIPTASE ACTIVITY BY ELISA [J].
EBERLE, J ;
SEIBL, R .
JOURNAL OF VIROLOGICAL METHODS, 1992, 40 (03) :347-356